Crescent Biopharma, Inc. (CBIO)
10.90
+0.11
(+1.02%)
USD |
NASDAQ |
Jan 12, 16:00
10.90
0.00 (0.00%)
After-Hours: 18:23
Crescent Biopharma Market Cap: 151.43M for Jan. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| XOMA Royalty Corp. | 330.13M |
| Viridian Therapeutics, Inc. | 3.110B |
| DiaMedica Therapeutics, Inc. | 424.95M |
| Denali Therapeutics, Inc. | 2.805B |
| Praxis Precision Medicines, Inc. | 6.903B |
Market Cap Related Metrics
| Price to Book Value | 1.344 |
| Price | 10.90 |
| Earnings Yield | -201.6% |